osudhkosh

Generic

Insulin Aspart

17 brands available in the market

At a glance

Insulin Aspart is a rapid-acting human insulin analog used to improve glycemic control in adults and children with diabetes mellitus.

Description

Insulin Aspart is a rapid-acting human insulin analog used to improve glycemic control in diabetes mellitus. It contains 30% soluble insulin aspart and 70% protamine-crystallized insulin aspart. It is homologous with regular human insulin except for a single substitution of proline by aspartic acid at position B28. It binds to insulin receptors on muscle and fat cells, facilitating glucose uptake and inhibiting glucose output from the liver.

Indications
  • Improvement of glycemic control in adults and children with diabetes mellitus
Therapeutic class

Rapid Acting Insulin

Pharmacological class

Insulin Analog (Rapid-acting)

Pharmacology

The primary activity of Insulin Aspart is the regulation of glucose metabolism. It binds to insulin receptors on muscle and fat cells, facilitating cellular glucose uptake and simultaneously inhibiting glucose output from the liver. It is homologous with regular human insulin except for a single substitution of proline by aspartic acid at position B28, which ensures rapid absorption and faster onset of action.

Mechanism of action

Lowers blood glucose by binding to insulin receptors, facilitating glucose uptake in muscle and fat cells, and inhibiting glucose output from the liver.

Dosage

Adult Dose (Subcutaneous):

  • Type 1 Diabetes: 0.2-0.6 units/kg/day in divided doses; maintenance: 0.5-1 unit/kg/day; nonobese: 0.4-0.6; obese: 0.6-1.2
  • Type 2 Diabetes: Initial: 0.2-0.4 units/kg/day q8hr-q12hr; with intermediate (NPH) or long-acting insulin at bedtime
  • 50-75% of insulin requirements provided by intermediate- or long-acting insulin; remainder as rapid-acting insulin before or at mealtimes

Child Dose (Type 1, >2 years): 0.5-1 unit/kg/day; adolescents <1.2 units/kg/day

Administration

Administer within 15 minutes before a meal or within 20 minutes after starting a meal as subcutaneous injection in upper arm, thigh, buttock or abdominal wall; abdominal wall injection results in faster absorption; rotate injection sites; do not administer IV or in insulin infusion pumps.

Missed dose

If you miss a dose, check your blood sugar and take the next dose accordingly; consult your doctor.

Side effects

Side Effects:

  • Hypoglycemia
  • Injection site reactions (redness, swelling, pain)
  • Lipodystrophy
  • Pruritus
  • Rash
  • Allergic reactions
Precautions & warnings

Precautions:

  • Hypoglycemia is a common side effect; monitor blood sugar regularly
  • Always carry sugary food or fruit juice for hypoglycemia symptoms (cold sweats, pale skin, tremors, weakness, anxiety)
  • Rotate injection sites (to prevent lipodystrophy)
  • Opened vials/cartridges stay good at room temperature for up to 4 weeks; unopened vials must be refrigerated (2°C-8°C)
  • Do not use if preparation is no longer clear and colorless or contains particles
  • Caution in renal and hepatic impairment (dose adjustment may be needed)
Contraindications

Contraindications:

  • Hypoglycemia
  • Hypersensitivity to Insulin Aspart or any of its excipients
Drug interactions

Drug Interactions:

  • Oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, propoxyphene, salicylates, somatostatin analog, sulfonamide antibiotics increase effect
  • Corticosteroids, niacin, danazol, diuretics, sympathomimetic agents, isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, oral contraceptives, lithium decrease effect
  • Beta-blockers, clonidine may mask symptoms of hypoglycemia
Food interactions

Food Interactions: It is unsafe to consume alcohol with Insulin Aspart.

Use in pregnancy

Use in Pregnancy: Category B; generally considered safe; animal studies show low or no adverse effects; limited human studies.

Pregnancy Category: B — always consult a doctor before taking during pregnancy.

Use in lactation

Use in Lactation: Safe during breastfeeding; does not pass into breastmilk in significant amount and is not harmful to baby.

Pediatric use

>2 years: 0.5-1 unit/kg/day; adolescents <1.2 units/kg/day.

Geriatric use

No specific data for elderly; however caution advised (limited experience in patients >75 years).

Renal / hepatic impairment

Renal Impairment: Dose adjustments may be needed (dosage may be reduced); frequent blood glucose monitoring recommended.

Hepatic Impairment: Dose adjustments may be needed (dosage may be reduced); frequent blood glucose monitoring recommended.

Overdose effects

Overdose: No specific overdose definition for insulin; hypoglycemia may develop; mild episodes treated with oral glucose or sugary products; severe episodes with glucagon (0.5-1 mg) IM/SC or IV glucose; oral carbohydrate recommended after regaining consciousness.

Storage conditions

Store at 2°C to 8°C in refrigerator; do not freeze; protect from light.

Chemical structure

Insulin Aspart

Common questions

What is Insulin Aspart used for?
It is used to improve glycemic control in adults and children with diabetes mellitus.
How to use it?
Administer as subcutaneous injection within 15 minutes before or within 20 minutes after starting a meal; rotate injection sites.
What are the side effects?
Hypoglycemia, injection site reactions, lipodystrophy, allergic reactions.
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.